NA-Semax-Amidate vs Selank
Research Verdict
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
Quick Answers
Which is better, NA-Semax-Amidate or Selank?
Neither compound has a universal evidence advantage. Both peptides serve distinct research goals with comparable evidence; choose by target mechanism.
What is the key difference between NA-Semax-Amidate and Selank?
Selank is a clinically validated anxiolytic peptide; NA-Semax-Amidate is a commercial derivative with claims of enhanced bioavailability but no published evidence supporting those claims.
Evidence Comparison
Selank: Russian RCT (Semenova 2010, n=38), approved anxiolytic in Russia with published pharmacokinetic characterization. NA-Semax-Amidate: vendor-created modification of semax with an amidated N-acetyl group - no published clinical or preclinical studies exist independent of peptide vendors. Selank is categorically stronger.
Evidence Context Favoring NA-Semax-Amidate
Only in vendor-driven exploratory contexts where the specific structural modification is being studied - no evidence supports choosing it over selank.
Evidence Context Favoring Selank
Any research context requiring anxiolytic peptide evidence; selank is the only compound in this pairing with published human data.
Side-by-Side Snapshot
| Evidence grade | NA-Semax-Amidate: Level D Selank: Level C |
|---|---|
| Research status | NA-Semax-Amidate: Early Research Selank: Approved Outside US |
| Primary category | NA-Semax-Amidate: Cognitive & Nootropic Selank: Cognitive & Nootropic |
| Cited studies | NA-Semax-Amidate: 3 Selank: 2 |